Exact Sciences will release its Q3 2025 earnings on November 3, providing crucial insights into its financial performance and market position. This announcement is significant for investors and industry stakeholders as it reflects the company’s ongoing commitment to innovation in cancer diagnostics.
MADISON, Wis.–(BUSINESS WIRE)–Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its third quarter 2025 financial results after the close of the U.S. financial markets on November 3, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress. Third quarter 2025 webcast & conference call details Date: M
Source: Original Press Release
